The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AGENUS INC COM NEW 00847G705 160 18,517 SH   SOLE   18,517 0 0
ALEXION PHARMACEUTICALS INC COM 015351109 1,075 5,949 SH   SOLE   5,949 0 0
AMERISOURCEBERGEN CORP COM 03073E105 713 6,707 SH   SOLE   6,707 0 0
CATALYST PHARMACEUTICALS INC COM 14888U101 334 80,890 SH   SOLE   80,890 0 0
CIGNA CORPORATION COM 125509109 784 4,842 SH   SOLE   4,842 0 0
CYNOSURE INC CL A 232577205 983 25,475 SH   SOLE   25,475 0 0
DEXCOM INC COM 252131107 1,240 15,504 SH   SOLE   15,504 0 0
HUMANA INC COM 444859102 739 3,862 SH   SOLE   3,862 0 0
LILLY ELI & CO COM 532457108 1,314 15,738 SH   SOLE   15,738 0 0
MALLINCKRODT PUB LTD CO SHS G5785G107 963 8,177 SH   SOLE   8,177 0 0
NEUROCRINE BIOSCIENCES INC COM 64125C109 410 8,593 SH   SOLE   8,593 0 0
RECEPTOS INC COM 756207106 428 2,251 SH   SOLE   2,251 0 0
REGENERON PHARMACEUTICALS COM 75886F107 1,170 2,294 SH   SOLE   2,294 0 0
SEATTLE GENETICS INC COM 812578102 424 8,768 SH   SOLE   8,768 0 0
THORATEC CORP COM NEW 885175307 1,047 23,486 SH   SOLE   23,486 0 0
ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 338 3,299 SH   SOLE   3,299 0 0
UNITED THERAPEUTICS CORP DEL COM 91307C102 1,741 10,009 SH   SOLE   10,009 0 0
UNIVERSAL HLTH SVCS INC CL B 913903100 2,084 14,663 SH   SOLE   14,663 0 0
ZELTIQ AESTHETICS INC COM 98933Q108 535 18,165 SH   SOLE   18,165 0 0
ZOETIS INC CL A 98978V103 721 14,956 SH   SOLE   14,956 0 0